Barbara Hendrickson to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Barbara Hendrickson has written about Dose-Response Relationship, Drug.
Connection Strength
0.057
-
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2021 06 05; 397(10290):2169-2181.
Score: 0.033
-
RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 a1 and a2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human Study. Adv Ther. 2017 06; 34(6):1364-1381.
Score: 0.025